References
- Werner CA, Dohner H, Joos S, et al High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol 1997;151:335–342.
- Nagel S, Leich E, Quentmeier H, et al Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma. Leuk Lymphoma 2010; In press.
- Bea S, Salaverria I, Armengol L, et al Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. Blood 2009;113:3059–3069.
- Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, et al Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 2007;109:271–280.
- Dyer MJ, Fischer P, Nacheva E, Labastide W, Karpas A. A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t (14;18) and t(4;11) chromosomal translocations. Blood 1990;75:709–714.
- Kobayashi H, Espinosa R III, Thirman MJ, et al Variability of 11q23 rearrangements in hematopoietic cell lines identified with fluorescence in situ hybridization. Blood 1993;81:3027–3033.
- Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 1997;89:215–225.
- Cox C, Bignell G, Greenman C, et al A survey of homozygous deletions in human cancer genomes. Proc Natl Acad Sci USA 2005;102:4542–4547.
- Fechter A, Buettel I, Kuehnel E, Savelyeva L, Schwab M. Common fragile site FRA11G and rare fragile site FRA11B at 11q23.3 encompass distinct genomic regions. Genes Chromosomes Cancer 2007;46:98–106.